Samantha Pohlman, PA
Physician Assistant · Lake Barrington, ILNPI 1487160131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $952, 4.5 times the $214 reported in 2021.
Across 102 payments — averaging $25.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$354
- Sumitomo Pharma America, Inc.$287
- Johnson & Johnson$212
- Urogen Pharma, Inc.$198
- Myovant Sciences Inc.$150
- Axonics, Inc.$150
- plus $1K from 25 others
Across 31 payments — averaging $1539.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$48K
What the payments were for
- Food & beverage$2,551100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $354 |
| Sumitomo Pharma America, Inc. | 11 | $287 |
| Johnson & Johnson | 4 | $212 |
| Urogen Pharma, Inc. | 4 | $198 |
| Myovant Sciences Inc. | 5 | $150 |
| Axonics, Inc. | 5 | $150 |
| Coloplast | 17 | $148 |
| Inari Medical, Inc. | 1 | $126 |
| AstraZeneca | 6 | $121 |
| Teleflex LLC | 3 | $108 |
| 180 Medical, Inc. | 3 | $76 |
| Dendreon Pharmaceuticals LLC | 3 | $70 |
| Ferring Pharmaceuticals Inc. | 3 | $58 |
| Therapeuticsmd, Inc. | 3 | $58 |
| Astellas Pharma US Inc | 3 | $52 |
| Olympus America Inc. | 1 | $49 |
| Immunitybio, Inc. | 2 | $45 |
| Clarus Therapeutics Inc. | 1 | $32 |
| Merck | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Boston Scientific | 1 | $23 |
| Amgen | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Bayer | 1 | $20 |
| Blue Earth Diagnostics | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Profound Medical Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$143
- FLOWTRIEVER CATHETER, S$126
- CT THROMBECTOMY SYSTEM KIT$126
- JELMYTO$109
- ZUSDURI$109
How this compares
$2,551 in reported general payments places this provider in the 85th percentile of 3,912 physician assistant providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 66 | $72,828 |
| GemtesaVibegron | 64 | $68,668 |
| Tamsulosin Hcl | 469 | $8,035 |
| Finasteride | 198 | $2,891 |
| Silodosin | 36 | $2,424 |
| Dutasteride | 78 | $2,395 |
| Estradiol | 38 | $2,393 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 56 | $1,171 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 74 | $928 |
| Potassium Citrate ErPotassium Citrate | 11 | $795 |
| Solifenacin Succinate | 23 | $565 |
| Testosterone Cypionate | 15 | $564 |
| Desmopressin Acetate | 12 | $456 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $370 |
| Cefdinir | 17 | $294 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $52 | $72,82866 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $287 | $68,66864 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Lake Barrington
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.